The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer

Journal of Clinical Gastroenterology

Volumn 42, Issue 3, 2008, Pages 279-283

  Ogura, Keiji ^a,b   Hirata, Yoshihiro ^a   Yanai, Ayako ^a   Shibata, Wataru ^a   Ohmae, Tomoya ^a   Mitsuno, Yuzo ^a   Maeda, Shin ^a   Watabe, Hirotsugu ^a   Yamaji, Yutaka ^a   Okamoto, Makoto ^a   Yoshida, Haruhiko ^a   Kawabe, Takao ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Eradication; Gastric cancer; Helicobacter pylori; Prevention

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CANCER DIAGNOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPY; ERADICATION THERAPY; FEMALE; HAZARD RATIO; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERSISTENT INFECTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; STOMACH CANCER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-INFECTIVE AGENTS; ANTIBODIES, BACTERIAL; BIOPSY; DRUG THERAPY, COMBINATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; JAPAN; MALE; METRONIDAZOLE; MIDDLE AGED; PROTON PUMPS; RETROSPECTIVE STUDIES; STOMACH; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 39749169748     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000248006.80699.7f     Document Type: Article

References (17)

1. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-1131.
2. Huang JQ, Zheng GF, Sumanac K, et al. Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology. 2003;125:1636-1644.
3. Maeda S, Yoshida H, Ogura K, et al. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs. Cancer. 2000;88:1530-1535.
4. Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001;345:784-789.
5. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst. 2000;92:1607-1612.
6. Wong BC, Lam SK, Wong WM, et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187-194.
7. Uemura N, Mukai T, Okamoto S, et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev. 1997;6:639-642.
8. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating Helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol. 2005;100:1037-1042.
9. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer. 1998;1:10-24.
10. Sugano H, Nakamura K, Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32(suppl 2):329-347.
11. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-766.
12. Maeda S, Yoshida H, Ikenoue T, et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut. 1999;44:336-341.
13. Cover TL, Glupczynski Y, Lage AP, et al. Serologic detection of infection with cagA+ Helicobacter pylori strains. J Clin Microbiol. 1995;33:1496-1500.
14. Weel JF, van der Hulst RW, Gerrits Y, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996;173:1171-1175.
15. Ching CK, Wong BC, Kwok E, et al. Prevalence of cagA-bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol. 1996;91:949-953.
16. Ogura K, Maeda S, Nakao M, et al. Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil. J Exp Med. 2000;192:1601-1610.
17. Watabe H, Mitsushima T, Yamaji Y, et al. Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study. Gut. 2005;54:764-768.